Safe Reintroduction of Cardiovascular Services During the COVID-19 Pandemic: From the North American Society Leadership

David A. Wood; Ehtisham Mahmud; Vinod H. Thourani; Janarthanan Sathananthan; Alice Virani; Athena Poppas; Robert A. Harrington; Joseph A. Dearani; Madhav Swaminathan; Andrea M. Russo; Ron Blankstein; Sharmila Dorbala; James Carr; Sean Virani; Kenneth Gin; Alan Packard; Vasken Dilsizian; Jean François Légaré; Jonathon Leipsic; John G. Webb; Andrew D. Krahn

doi:10.1016/j.cjca.2020.04.031

Safe Reintroduction of Cardiovascular Services During the COVID-19 Pandemic: From the North American Society Leadership

David A. Wood^*, Ehtisham Mahmud, Vinod H. Thourani, Janarthanan Sathananthan, Alice Virani, Athena Poppas, Robert A. Harrington, Joseph A. Dearani, Madhav Swaminathan, Andrea M. Russo, Ron Blankstein, Sharmila Dorbala, James Carr, Sean Virani, Kenneth Gin, Alan Packard, Vasken Dilsizian, Jean François Légaré, Jonathon Leipsic, John G. WebbAndrew D. Krahn

^*Corresponding author for this work

Radiology

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Original language	English (US)
Pages (from-to)	971-976
Number of pages	6
Journal	Canadian Journal of Cardiology
Volume	36
Issue number	7
DOIs	https://doi.org/10.1016/j.cjca.2020.04.031
State	Published - Jul 2020

Funding

Dr. Wood has received unrestricted grant support from Edwards Lifesciences and Abbott Vascular; and has served as a consultant to Edwards Lifesciences, Medtronic, Abbott Vascular, and Boston Scientific. Dr. Mahmud has served as a consultant for Abiomed, Medtronic, and Boston Scientific; has received clinical trial support from Corindus; has served as Chairman of the Data Safety Monitoring Board for CAD III and CAD IV studies sponsored by Shockwave, Inc.; and has served as Chairman of the Data Safety Monitoring Board for the EluNIR-HBR Study sponsored by Medinol. Dr. Thourani has served as an advisor for and/or received research support from Edwards Lifesciences, Abbott Vascular, Gore Vascular, Boston Scientific, and JenaValve. Dr Sathananthan has served as a consultant for Edwards Lifesciences and Medtronic. Dr. Harrington has served on an Advisory Committee for Element Science. Dr. Russo has received grant support from Boston Scientific and Medilynx; and has served as a steering committee member (without honoraria) for Boston Scientific and Apple. Dr. Dorbala has served as an advisor and has received institutional research support from Pfizer and GE Healthcare. Dr. Carr has received research funding from Siemens, Bayer, and Guerbet; and has served as a consultant for Siemens and Bayer. Dr. Virani has served as an advisor to Medtronic; and has served as a consultant to Abbott Vascular. Dr. Leipsic has served as a consultant to and has stock options in HeartFlow and Circle CVI; has received research support from GE Healthcare and Edwards Lifesciences; has CT core laboratory research agreements with Edwards, Abbott, Medtronic, and NEOVASC, for which he takes no compensation; and has served on the Speakers Bureau of GE Healthcare and Philips. Dr. Webb has served as a consultant to Edwards Lifesciences, Abbott, and Boston Scientific. Dr. Krahn has served as a consultant for Medtronic. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Dr. Wood has received unrestricted grant support from Edwards Lifesciences and Abbott Vascular; and has served as a consultant to Edwards Lifesciences, Medtronic, Abbott Vascular, and Boston Scientific. Dr. Mahmud has served as a consultant for Abiomed, Medtronic, and Boston Scientific; has received clinical trial support from Corindus; has served as Chairman of the Data Safety Monitoring Board for CAD III and CAD IV studies sponsored by Shockwave, Inc.; and has served as Chairman of the Data Safety Monitoring Board for the EluNIR-HBR Study sponsored by Medinol. Dr. Thourani has served as an advisor for and/or received research support from Edwards Lifesciences, Abbott Vascular, Gore Vascular, Boston Scientific, and JenaValve. Dr Sathananthan has served as a consultant for Edwards Lifesciences and Medtronic. Dr. Harrington has served on an Advisory Committee for Element Science. Dr. Russo has received grant support from Boston Scientific and Medilynx; and has served as a steering committee member (without honoraria) for Boston Scientific and Apple. Dr. Dorbala has served as an advisor and has received institutional research support from Pfizer and GE Healthcare. Dr. Carr has received research funding from Siemens, Bayer, and Guerbet; and has served as a consultant for Siemens and Bayer. Dr. Virani has served as an advisor to Medtronic; and has served as a consultant to Abbott Vascular. Dr. Leipsic has served as a consultant to and has stock options in HeartFlow and Circle CVI; has received research support from GE Healthcare and Edwards Lifesciences; has CT core laboratory research agreements with Edwards, Abbott, Medtronic, and NEOVASC, for which he takes no compensation; and has served on the Speakers Bureau of GE Healthcare and Philips. Dr. Webb has served as a consultant to Edwards Lifesciences, Abbott, and Boston Scientific. Dr. Krahn has served as a consultant for Medtronic. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Keywords

COVID-19 pandemic
cardiac computed tomography
cardiac magnetic resonance imaging
cardiovascular procedures
cardiovascular surgery
diagnostic tests
echocardiography
electrophysiology
interventional cardiology
nuclear cardiac imaging

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.cjca.2020.04.031

Cite this

Wood, D. A., Mahmud, E., Thourani, V. H., Sathananthan, J., Virani, A., Poppas, A., Harrington, R. A., Dearani, J. A., Swaminathan, M., Russo, A. M., Blankstein, R., Dorbala, S., Carr, J., Virani, S., Gin, K., Packard, A., Dilsizian, V., Légaré, J. F., Leipsic, J., ... Krahn, A. D. (2020). Safe Reintroduction of Cardiovascular Services During the COVID-19 Pandemic: From the North American Society Leadership. Canadian Journal of Cardiology, 36(7), 971-976. https://doi.org/10.1016/j.cjca.2020.04.031

@article{d2cebf957aad46279484142080bf38d5,

title = "Safe Reintroduction of Cardiovascular Services During the COVID-19 Pandemic: From the North American Society Leadership",

keywords = "COVID-19 pandemic, cardiac computed tomography, cardiac magnetic resonance imaging, cardiovascular procedures, cardiovascular surgery, diagnostic tests, echocardiography, electrophysiology, interventional cardiology, nuclear cardiac imaging",

author = "Wood, {David A.} and Ehtisham Mahmud and Thourani, {Vinod H.} and Janarthanan Sathananthan and Alice Virani and Athena Poppas and Harrington, {Robert A.} and Dearani, {Joseph A.} and Madhav Swaminathan and Russo, {Andrea M.} and Ron Blankstein and Sharmila Dorbala and James Carr and Sean Virani and Kenneth Gin and Alan Packard and Vasken Dilsizian and L{\'e}gar{\'e}, {Jean Fran{\c c}ois} and Jonathon Leipsic and Webb, {John G.} and Krahn, {Andrew D.}",

note = "Funding Information: Dr. Wood has received unrestricted grant support from Edwards Lifesciences and Abbott Vascular; and has served as a consultant to Edwards Lifesciences, Medtronic, Abbott Vascular, and Boston Scientific. Dr. Mahmud has served as a consultant for Abiomed, Medtronic, and Boston Scientific; has received clinical trial support from Corindus; has served as Chairman of the Data Safety Monitoring Board for CAD III and CAD IV studies sponsored by Shockwave, Inc.; and has served as Chairman of the Data Safety Monitoring Board for the EluNIR-HBR Study sponsored by Medinol. Dr. Thourani has served as an advisor for and/or received research support from Edwards Lifesciences, Abbott Vascular, Gore Vascular, Boston Scientific, and JenaValve. Dr Sathananthan has served as a consultant for Edwards Lifesciences and Medtronic. Dr. Harrington has served on an Advisory Committee for Element Science. Dr. Russo has received grant support from Boston Scientific and Medilynx; and has served as a steering committee member (without honoraria) for Boston Scientific and Apple. Dr. Dorbala has served as an advisor and has received institutional research support from Pfizer and GE Healthcare. Dr. Carr has received research funding from Siemens, Bayer, and Guerbet; and has served as a consultant for Siemens and Bayer. Dr. Virani has served as an advisor to Medtronic; and has served as a consultant to Abbott Vascular. Dr. Leipsic has served as a consultant to and has stock options in HeartFlow and Circle CVI; has received research support from GE Healthcare and Edwards Lifesciences; has CT core laboratory research agreements with Edwards, Abbott, Medtronic, and NEOVASC, for which he takes no compensation; and has served on the Speakers Bureau of GE Healthcare and Philips. Dr. Webb has served as a consultant to Edwards Lifesciences, Abbott, and Boston Scientific. Dr. Krahn has served as a consultant for Medtronic. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Funding Information: Dr. Wood has received unrestricted grant support from Edwards Lifesciences and Abbott Vascular; and has served as a consultant to Edwards Lifesciences, Medtronic, Abbott Vascular, and Boston Scientific. Dr. Mahmud has served as a consultant for Abiomed, Medtronic, and Boston Scientific; has received clinical trial support from Corindus; has served as Chairman of the Data Safety Monitoring Board for CAD III and CAD IV studies sponsored by Shockwave, Inc.; and has served as Chairman of the Data Safety Monitoring Board for the EluNIR-HBR Study sponsored by Medinol. Dr. Thourani has served as an advisor for and/or received research support from Edwards Lifesciences, Abbott Vascular, Gore Vascular, Boston Scientific, and JenaValve. Dr Sathananthan has served as a consultant for Edwards Lifesciences and Medtronic. Dr. Harrington has served on an Advisory Committee for Element Science. Dr. Russo has received grant support from Boston Scientific and Medilynx; and has served as a steering committee member (without honoraria) for Boston Scientific and Apple. Dr. Dorbala has served as an advisor and has received institutional research support from Pfizer and GE Healthcare. Dr. Carr has received research funding from Siemens, Bayer, and Guerbet; and has served as a consultant for Siemens and Bayer. Dr. Virani has served as an advisor to Medtronic; and has served as a consultant to Abbott Vascular. Dr. Leipsic has served as a consultant to and has stock options in HeartFlow and Circle CVI; has received research support from GE Healthcare and Edwards Lifesciences; has CT core laboratory research agreements with Edwards, Abbott, Medtronic, and NEOVASC, for which he takes no compensation; and has served on the Speakers Bureau of GE Healthcare and Philips. Dr. Webb has served as a consultant to Edwards Lifesciences, Abbott, and Boston Scientific. Dr. Krahn has served as a consultant for Medtronic. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. ",

year = "2020",

month = jul,

doi = "10.1016/j.cjca.2020.04.031",

language = "English (US)",

volume = "36",

pages = "971--976",

journal = "Canadian Journal of Cardiology",

issn = "0828-282X",

publisher = "Elsevier Inc.",

number = "7",

}

Wood, DA, Mahmud, E, Thourani, VH, Sathananthan, J, Virani, A, Poppas, A, Harrington, RA, Dearani, JA, Swaminathan, M, Russo, AM, Blankstein, R, Dorbala, S, Carr, J, Virani, S, Gin, K, Packard, A, Dilsizian, V, Légaré, JF, Leipsic, J, Webb, JG & Krahn, AD 2020, 'Safe Reintroduction of Cardiovascular Services During the COVID-19 Pandemic: From the North American Society Leadership', Canadian Journal of Cardiology, vol. 36, no. 7, pp. 971-976. https://doi.org/10.1016/j.cjca.2020.04.031

TY - JOUR

T1 - Safe Reintroduction of Cardiovascular Services During the COVID-19 Pandemic

T2 - From the North American Society Leadership

AU - Wood, David A.

AU - Mahmud, Ehtisham

AU - Thourani, Vinod H.

AU - Sathananthan, Janarthanan

AU - Virani, Alice

AU - Poppas, Athena

AU - Harrington, Robert A.

AU - Dearani, Joseph A.

AU - Swaminathan, Madhav

AU - Russo, Andrea M.

AU - Blankstein, Ron

AU - Dorbala, Sharmila

AU - Carr, James

AU - Virani, Sean

AU - Gin, Kenneth

AU - Packard, Alan

AU - Dilsizian, Vasken

AU - Légaré, Jean François

AU - Leipsic, Jonathon

AU - Webb, John G.

AU - Krahn, Andrew D.

N1 - Funding Information: Dr. Wood has received unrestricted grant support from Edwards Lifesciences and Abbott Vascular; and has served as a consultant to Edwards Lifesciences, Medtronic, Abbott Vascular, and Boston Scientific. Dr. Mahmud has served as a consultant for Abiomed, Medtronic, and Boston Scientific; has received clinical trial support from Corindus; has served as Chairman of the Data Safety Monitoring Board for CAD III and CAD IV studies sponsored by Shockwave, Inc.; and has served as Chairman of the Data Safety Monitoring Board for the EluNIR-HBR Study sponsored by Medinol. Dr. Thourani has served as an advisor for and/or received research support from Edwards Lifesciences, Abbott Vascular, Gore Vascular, Boston Scientific, and JenaValve. Dr Sathananthan has served as a consultant for Edwards Lifesciences and Medtronic. Dr. Harrington has served on an Advisory Committee for Element Science. Dr. Russo has received grant support from Boston Scientific and Medilynx; and has served as a steering committee member (without honoraria) for Boston Scientific and Apple. Dr. Dorbala has served as an advisor and has received institutional research support from Pfizer and GE Healthcare. Dr. Carr has received research funding from Siemens, Bayer, and Guerbet; and has served as a consultant for Siemens and Bayer. Dr. Virani has served as an advisor to Medtronic; and has served as a consultant to Abbott Vascular. Dr. Leipsic has served as a consultant to and has stock options in HeartFlow and Circle CVI; has received research support from GE Healthcare and Edwards Lifesciences; has CT core laboratory research agreements with Edwards, Abbott, Medtronic, and NEOVASC, for which he takes no compensation; and has served on the Speakers Bureau of GE Healthcare and Philips. Dr. Webb has served as a consultant to Edwards Lifesciences, Abbott, and Boston Scientific. Dr. Krahn has served as a consultant for Medtronic. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Funding Information: Dr. Wood has received unrestricted grant support from Edwards Lifesciences and Abbott Vascular; and has served as a consultant to Edwards Lifesciences, Medtronic, Abbott Vascular, and Boston Scientific. Dr. Mahmud has served as a consultant for Abiomed, Medtronic, and Boston Scientific; has received clinical trial support from Corindus; has served as Chairman of the Data Safety Monitoring Board for CAD III and CAD IV studies sponsored by Shockwave, Inc.; and has served as Chairman of the Data Safety Monitoring Board for the EluNIR-HBR Study sponsored by Medinol. Dr. Thourani has served as an advisor for and/or received research support from Edwards Lifesciences, Abbott Vascular, Gore Vascular, Boston Scientific, and JenaValve. Dr Sathananthan has served as a consultant for Edwards Lifesciences and Medtronic. Dr. Harrington has served on an Advisory Committee for Element Science. Dr. Russo has received grant support from Boston Scientific and Medilynx; and has served as a steering committee member (without honoraria) for Boston Scientific and Apple. Dr. Dorbala has served as an advisor and has received institutional research support from Pfizer and GE Healthcare. Dr. Carr has received research funding from Siemens, Bayer, and Guerbet; and has served as a consultant for Siemens and Bayer. Dr. Virani has served as an advisor to Medtronic; and has served as a consultant to Abbott Vascular. Dr. Leipsic has served as a consultant to and has stock options in HeartFlow and Circle CVI; has received research support from GE Healthcare and Edwards Lifesciences; has CT core laboratory research agreements with Edwards, Abbott, Medtronic, and NEOVASC, for which he takes no compensation; and has served on the Speakers Bureau of GE Healthcare and Philips. Dr. Webb has served as a consultant to Edwards Lifesciences, Abbott, and Boston Scientific. Dr. Krahn has served as a consultant for Medtronic. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

PY - 2020/7

Y1 - 2020/7

KW - COVID-19 pandemic

KW - cardiac computed tomography

KW - cardiac magnetic resonance imaging

KW - cardiovascular procedures

KW - cardiovascular surgery

KW - diagnostic tests

KW - echocardiography

KW - electrophysiology

KW - interventional cardiology

KW - nuclear cardiac imaging

UR - http://www.scopus.com/inward/record.url?scp=85087378783&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85087378783&partnerID=8YFLogxK

U2 - 10.1016/j.cjca.2020.04.031

DO - 10.1016/j.cjca.2020.04.031

M3 - Article

C2 - 32380228

AN - SCOPUS:85087378783

SN - 0828-282X

VL - 36

SP - 971

EP - 976

JO - Canadian Journal of Cardiology

JF - Canadian Journal of Cardiology

IS - 7

ER -

Safe Reintroduction of Cardiovascular Services During the COVID-19 Pandemic: From the North American Society Leadership

Funding

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this